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Mitochondria exist in large numbers per cell. Therefore, the strength of natural selection on individual 
mtDNAs for their contribution to cellular fitness is weak whereas the strength of selection in favor of 
mtDNAs that increase their own replication without regard for cellular functions is strong. This problem 
has been solved for most mitochondrial genes by their transfer to the nucleus but a few critical genes remain 
encoded by mtDNA. Organisms manage the evolution of mtDNA to prevent mutational decay of essential 
services mitochondria provide to their hosts. Bottlenecks of mitochondrial numbers in female germlines 
increase the homogeneity of mtDNAs within cells and allow intraorganismal selection to eliminate cells with 
low quality mitochondria. Mechanisms of intracellular ‘quality control’ allow direct selection on the 
competence of individual mtDNAs. These processes maintain the integrity of mtDNAs within the germline 
but are inadequate to indefinitely maintain mitochondrial function in somatic cells. 
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Introduction	
The world population of human mitochondrial genomes (mtDNAs) is immense. Our planet is currently 
home to somewhat fewer than 1010 human bodies, each containing 1013 cells [1], each containing 103 or 
more mtDNAs [2], for a rough estimate of 1026 total mtDNAs. Mitochondrial genetic variation is 
distributed within cells, among cells within bodies, and among bodies. Evolutionary processes of genetic 
drift and natural selection can occur at all these levels (Fig. 1) [3–5]. 
Mutation generates variation among mtDNAs within cells (heteroplasmy). A heteroplasmic herd of 
mtDNAs is subject to ‘relaxed’ replication, some mtDNAs are copied many times while others remain 
unreplicated, then mtDNAs are randomly sorted into daughter cells at mitosis. Such stochastic processes 
cause haplotype frequencies to drift within cell lineages, and to diverge among cells [6, 7]. But mtDNA is 
also subject to natural selection within and among cells. A variant that replicates faster than other members 
of its herd will increase its representation within a cell, and a cell lineage with a more efficient herd may 
generate daughter cells, with daughter herds, faster than cell lineages with less efficient herds [3]. Adaptive 
evolution of mtDNA for the benefit of bodies threatens to be overwhelmed by evolutionary processes within 
and among cells. 
At first glance, mitochondrial efficiency should be subject to an insidious process of mutational 
degradation because purifying selection is ineffective at maintaining the function of large populations of 
interchangeable units that are judged by collective performance [8]. Suppose that a cell contains 1,000 
copies of mtDNA and a mutation in one reduces that copy’s contribution to oxidative phosphorylation by 
10%. The effect of this mutation is diluted a thousand-fold within the cell such that cellular efficiency is 
reduced by only 0.01%, a shortfall that could be compensated by increasing mtDNA by a single copy until 
the next mutation that reduces cellular efficiency (and so on, in a ratchet-like process that steadily degrades 
mitochondrial function). By the same reasoning, positive selection for enhanced efficiency should be 
similarly ineffective because a mutation that increases efficiency by 10% would cause only a minuscule 
improvement in cellular function. In contrast, a mutant mtDNA that replicates 10% faster than nonmutant 
mtDNA in the same cell would increase steadily in frequency within its cell lineage even if mutant mtDNAs 
were associated with impaired cellular function.  
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When viewed from this perspective, the maintenance of mitochondrial function is a classic problem 
of the provision of public goods. Contributions to cellular function benefit the cell, and all its inhabitants, 
but replication is a private good of individual mtDNAs. Thus, mtDNAs are subject to a tragedy of the 
cytoplasmic commons [9]. The risk of mutational decay of mtDNA is commonly ascribed to Muller’s 
ratchet, the inexorable fixation of deleterious mutations in asexual lineages by random sampling from finite 
populations [3, 10, 11], but Muller’s ratchet and the public-goods problem are distinct. Muller’s ratchet 
turns more rapidly as population size decreases, but the public-goods problem is exacerbated as the number 
of mitochondria per cell increases. Social scientists have long recognized that public goods are easier to 
provide in smaller groups [12]. The mitochondrial public-goods problem appears to have been solved 
evolutionarily by a combination of mechanisms that reduce effective group size and convert oxidative 
phosphorylation into a private good of individual mtDNAs.  
Nuclear	genes	manage	mitochondrial	evolution	for	bodily	benefit	
Mitochondria descend from an ancient endosymbiotic bacterium whose genome has dwindled by loss of 
non-essential genes and transfer of essential genes to the nucleus. About 1,000 genes are required to make a 
fully-functional mitochondrion, but mammalian mtDNA encodes only 13 membrane-bound proteins, two 
ribosomal RNAs, and 22 tRNAs. Most proteins essential for mitochondrial function are encoded by nuclear 
loci and shared among all of a cell’s mitochondria [13, 14]. Thus, the size of the group that provides each 
nuclear-encoded protein is reduced to a single gene in haploid cells, or two genes in diploid cells, with very 
limited opportunities for within-cell selection. The performance of nuclear-encoded proteins is judged at the 
cellular or organismal level. Of particular importance, many of the genes responsible for replication of 
mtDNA, for fusion–fission cycles of mitochondria, and for apoptotic cell death, are nuclear-encoded and 
will have evolved to manage mtDNA populations for organismal benefit.  
Nuclear genes are the herdsmen of domesticated mtDNAs. Our bodies possess multitudes of 
mitochondria in large herds within cells and myriad cellular herds within bodies. Because of these immense 
numbers, mitochondrial genomes are subject to significant evolution both within cells and among cells 
within bodies. If mitochondria reproduced at will within herds, without regard for cellular function, then 
the bioenergetic services mitochondria provide for their cellular and bodily hosts would steadily deteriorate, 
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both within and across generations. Somatic herds, like the bodies they inhabit, deteriorate over time, but 
the next generation of bodies starts life with healthy herds. Nuclear genes have evolved to manage 
mitochondrial evolution for bodily benefit. Such management includes selective breeding of mitochondria 
with superior traits. Female germ cells are the stud farms that nurture and select the breeding stock that will 
populate the mitochondrial herds of the next generation. 
Bottlenecks	increase	mtDNA	homogeneity	within	cells	
A body’s mtDNAs are highly similar despite huge numbers in zygotes. This genetic homogeneity, together 
with large intergenerational shifts in the frequency of variant mtDNAs when these arise, provide evidence 
for one or more postzygotic restrictions of mitochondrial numbers [15]. Tight germline bottlenecks ensure 
that all copies of mtDNA in a matrilineal pedigree have a recent common ancestor and that heteroplasmy 
reflects recent mutation of mtDNA. Bottlenecks reduce the effective number of haplotypes segregating 
within cell lineages and lessen the public-goods problem because fewer distinct haplotypes contribute to 
(and share in) the cellular good of oxidative phosphorylation.  
Bottlenecks redistribute variation in mtDNA from within to among cells, enhancing the effectiveness of 
natural selection on cellular function [16–18]. Although bottlenecks help maintain mtDNA quality for the 
long-term ‘good of the species’, this is an insufficient explanation for the evolution of bottlenecks. Nuclear 
and mitochondrial gene lineages part company every second generation, on average, when male-derived 
mtDNAs are eliminated from zygotes. Therefore, nuclear alleles that enforce a bottleneck, when 
maternally-derived, experience the same pool of mtDNAs, when paternally-derived, as alleles that fail to 
enforce a bottleneck. All share in the long-term benefit. For this reason, the selective maintenance of 
mitochondrial bottlenecks requires a short-term benefit for nuclear genes. 
A bottleneck increases the average fitness of surviving offspring after selection but does not 
necessarily increase the average fitness of offspring before selection [16]. The solution to this conundrum is 
for selection to occur within female germlines before major maternal investment (Fig. 2). Parallel 
bottlenecks in multiple cell lineages of the germline increases mitochondrial variance among oocytes and 
provide a robust short-term advantage for nuclear genes if investment can be directed to oocytes of higher 
quality [19, 20]. Such a redistributive process could occur before formation of primordial follicles, if 
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primordial germ cells or oogonia with superior mtDNA have a proliferative advantage, or after formation 
of follicles, if oocytes of poor mitochondrial quality preferentially undergo atresia [21, 22]. Zygotic 
bottlenecks could serve the same purpose if mothers increase postzygotic care of superior offspring by 
selective abortion of low quality embryos. 
In summary, germline bottlenecks reduce mitochondrial genetic variation within cells and increase 
variation among cells, thereby enhancing the effectiveness of cellular selection for mitochondrial function. 
Bottlenecks also decrease genetic variation of mtDNA within offspring bodies, thereby enhancing the 
effectiveness of organismal selection on mitochondrial traits. Cellular selection and organismal selection are 
likely to align for housekeeping functions of mtDNA, but soma-specific functions of mtDNA are not subject 
to selection within female germ lines. Germline selection is blind to strictly somatic functions, which will be 
selected only at the organismal level. Long-term evolution will therefore tend to favor soma-specific 
functions being performed by nuclear-encoded rather than mtDNA-encoded proteins. Indeed, 
mitochondrial proteins with tissue-specific isoforms are all nuclear-encoded [23]. 
Quality	control	within	cells	eliminates	defective	mtDNA	
Cellular selection of mtDNA occurs when cells undergo differential proliferation determined by variation in 
mtDNA-encoded genes. The process becomes more efficient if slow growth is converted to no growth by 
elimination of cells with poor quality mtDNA. Selective cell death also allows selection of mtDNA to occur 
within populations of non-dividing cells. Apoptosis, among other functions, may eliminate cells with 
catastrophic mitochondrial failure to protect nearby cells from uncontrolled production of reactive oxygen 
species [24, 25]. 
Selection among cells is a blunt instrument to eliminate a few malfunctioning mitochondria. Sharper 
tools can be deployed to cull the lame but spare the herd. Mitochondria undergo cycles of fission and fusion 
within cells. Multiple mitochondria are distributed throughout the cytoplasm at mitosis. Mitochondria fuse 
to form large networks before entry to S phase and then the networks fragment before the next cell division 
[26, 27]. Mitochondrial networks bud off parts, some of which are degraded, before surviving parts merge 
again with the network. This dynamic process of separation and reintegration is believed to function as a 
form of  intracellular ‘quality control’ in which mitochondrial parts of lower membrane potential are 
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eliminated by mitophagy [28–31]. Intracellular selection (mitophagy) and cellular selection (apoptosis) may 
work together to maintain the quality of mitochondrial herds. 
Fusion can be conjectured to increase the effectiveness of quality control by equilibrating soluble 
factors among mitochondrial parts. By this means, fusion followed by fission establishes a ‘level playing 
field’ that isolates mtDNA as a factor responsible for variation in competence among mitochondrial parts. 
Such a selective mechanism requires that mtDNAs are physically linked to their gene products and included 
within the parts that undergo selective mitophagy [32, 33]. Of particular interest are ‘kiss-and-run’ fusions 
in which soluble contents, but not nucleoids, are exchanged [34, 35]. tRNAs, unlike mitochondrially-
encoded proteins and rRNAs, are not membrane-tethered, and are likely to be exchanged during fusion. 
Therefore, fission fragments of mitochondrial networks are likely to contain tRNAs encoded by multiple 
mtDNAs. For this reason, intracellular quality control should be less effective at eliminating deleterious 
mutations of tRNAs. Indeed, mutations in tRNA genes are disproportionately common causes of heritable 
mitochondrial disease [36]. 
Intracellular selection helps solve the public-goods problem by converting public goods into private 
goods. Each mtDNA must demonstrate its oxidative prowess to be accepted as a member of the group 
within its cell. In this way, ‘compensation’ of individual mtDNAs is tied to their ‘performance’. Fission, 
fusion, and mitophagy undoubtedly have other functions to coordinate mitochondrial numbers with 
metabolic demand. But, if mtDNAs are to be eliminated for whatever reason, a selective process is better 
than a random process. Many questions remain about quality control, including whether mitochondria are 
eliminated because of failure to meet an absolute standard of performance or a comparative standard (how 
well a part performs relative to another part). 
mtDNAs	evolve	‘selfish’	adaptations	that	promote	their	own	replication	
The metabolic functions of mtDNA are adaptive for organisms and cells and are maintained, in part, by 
cellular and intracellular selection. But do mtDNAs also possess intracellular adaptations—independent of 
cellular function—that have evolved because of competition among mtDNAs within cells? 
Intracellular selection favors mtDNAs that are superior competitors for a limited supply of replicases. 
Bottlenecks, in particular, create winners and losers. If passing through a bottleneck is likened to winning a 
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lottery, then intracellular selection favors mtDNAs that purchase extra tickets. As a consequence, female 
germ cells may contain more copies of mtDNA than the number that would be justified by cellular function 
alone. Organismal-level selection of nuclear-encoded factors would then favor compensating reductions in 
mtDNA replication. However, nuclear genes face the evolutionary challenge of maintaining replicative 
order despite rampant polymorphism of mitochondrial haplotypes that results from clonal evolution in 
maternal lineages creating nested, independently-evolving, clades of mtDNA [37].  
The control region, which contains origins of H-strand replication, is the most rapidly evolving 
segment of mtDNA [38, 39]. Rapid evolution of the non-coding control region is commonly ascribed to 
relaxation of selective constraints relative to coding sequences [37] but positive selection to increase an 
mtDNA’s representation within cells, and evade restraint by nuclear-encoded factors, should also be 
considered. Unfortunately, little is known about the regulation of mtDNA replication in female germlines. 
Mitochondria move within cells by interactions with microtubule motors [40]. Some locations within 
germ cells may be more propitious than others for long term persistence of mtDNAs. If mtDNAs can 
influence their own movement then mitochondria might be expected to congregate at these propitious sites. 
For example, if the cytoplasmic distribution of replicases is anisotropic then mtDNAs would benefit from 
moving to, or failing to move from, sites with a relative abundance of replicases. Similarly, an oocyte’s large 
stock of mitochondria is distributed among all cells of the early embryo, but only some cells become germ 
cell progenitors. Intracellular selection would favor mtDNA variants that had the knack of 
disproportionately segregating to germ cells rather than somatic cells.  
Oocytes of animals with ‘preformed’ germlines, such as frogs, contain determinants of future germ 
cells (‘germ plasm’) intermingled with large numbers of mitochondria in a perinuclear agglomeration 
known as the mitochondrial cloud or Balbiani body [41]. A mtDNA that was able to segregate together 
with germ plasm would thereby increase its own representation in the germline. By comparison, oocytes of 
animals with ‘epigenetic’ determination of germ cells, such as mammals, may contain few spatial cues of the 
future location of germ cells [42]. Strategic self-placement by mtDNAs is possible only if mtDNAs can 
influence where and when they move, and such movement could be accomplished by microtubule motors 
fueled by locally-synthesized ATP. Movement of mitochondria into and out of the Balbiani body, based on 
the local delivery of fuel to mitochondrial motors, has been proposed as a mechanism of selecting ‘healthy’ 
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mitochondria [43, 44]. In this case, what is good for the mitochondrion is probably also adaptive at the 
cellular and organismal level. 
Mitochondria are intimately involved in the initiation of apoptotic cell death [45, 46], a process that 
includes interactions between nuclear-encoded proteins, such as cytochrome c, and mtDNA-encoded 
proteins, such as subunits of cytochrome c oxidase [47]. Because of segregation of mtDNAs among oocytes, 
a mtDNA that increases the chance that its oocyte avoids apoptosis potentially increases its representation 
in the next generation, but the same is not true for nuclear genes or for mtDNAs in surrounding follicle 
cells. Therefore, one might expect adaptations of mtDNA to avoid apoptosis in the female germline and 
compensating adaptations of nuclear-encoded genes, especially at molecular interfaces where their protein 
products interact. 
Mitochondrial	breeding	stock	is	actively	managed	in	female	germlines	
Nuclear genes are inherited equally via eggs and sperm but mtDNAs are transmitted predominantly or 
exclusively via eggs. Paternal transmission of mtDNA, if it occurs, must be exceedingly rare [48]. If one 
were to trace the forebears of a zygotic mtDNA backward in time, these ancestors would have resided in a 
recurrent sequence of zygotes, blastomeres, embryonic stem cells, primordial germ cells (PGCs), oogonia, 
and oocytes embedded exclusively (or overwhelmingly) within female bodies. For this reason, the long-term 
evolution of mtDNA sequences will have been jointly determined by evolutionary change within female 
germlines and by survival and reproduction of female bodies.  
Fewer than a hundred extragonadal PGCs in an early embryo are the progenitors of all adult germ 
cells [49]. Descendants of these PGCs migrate to the developing ovary—roughly a thousand completing the 
trek—where oogonia proliferate before entering meiotic arrest as oocytes [50]. A subset of oocytes is 
surrounded by somatic cells to form primordial follicles and the remainder degenerates. From peak levels at 
mid pregnancy, follicles undergo progressive and continuous attrition until ovarian exhaustion at 
menopause. Of the 7 million follicles of a 20-week human fetus, 400,000 survive until birth, 200,000 remain 
at puberty, some hundreds are ovulated, and fewer than a thousand remain at menopause [51, 52]. During 
each ovarian cycle, a small cohort of follicles starts to grow, one follicle becomes dominant and the others 
cease growth and die. The oocyte of the dominant follicle finally completes meiosis—begun in the fetal 
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ovary—after its fertilization in the fallopian tube. What sources of variation among oocytes could justify 
such profligacy? Variation among mitochondrial herds may be one contributing factor. 
The zygotic endowment of mtDNAs does not resume replication until the blastocyst stage [53]. 
Therefore, the 200,000 or so copies of mtDNA in mature human oocytes [54] must be shared among many 
early embryonic cells. After this bottleneck, each pre-migratory human PGC contains fewer than ten 
mitochondria. The subsequent expansion of mitochondrial numbers is stupendous. Each oocyte of a 
primordial follicle contains about 6,000 copies of mtDNA. From a starting population of a few hundred 
mtDNAs in early PGCs, the 7 million human oocytes at mid-gestation are home to about 35 billion 
mitochondria! The final amplification of mtDNA within oocytes, that restores numbers to the 200,000 
copies of the preceding maternal oocyte, occurs during the ovarian cycle before ovulation [19]. 
The demographies of female germ cells, and of their mitochondria, strongly suggest that the 
principal bottleneck of mtDNA numbers occurs before PGCs arrive at the germinal ridge, perhaps before 
differentiation of PGCs. Somatic cells can be experimentally induced to form pluripotent stem cells (iPSCs) 
that mimic cells of the early embryonic inner cell mass, and this process is accompanied by drastic 
reduction of mtDNA numbers that recapitulates an early embryonic bottleneck [55, 56]. It is unclear 
whether the mitochondrial bottlenecks of iPSCs reflect a passive process, diminution by cellular 
proliferation without mtDNA replication, or instead involve active degradation of mtDNAs. 
Ample opportunities exist for cellular selection of mitochondrial function in the female germline. 
The gonadal migration of PGCs may be a strenuous test of ATP production for cells that set out with fewer 
than ten mitochondria: the proliferation of oogonia within ovaries may favor cell lineages with efficient 
mitochondrial herds; and metabolic testing of oocytes by follicles may weed out all but the best performing 
oocytes. (Follicle cells, it should be noted, are no more closely related to their own oocyte than to other 
oocytes of the female germline.) Finally, intracellular selection—quality control within oocytes—may also 
play a role [57].  
Experimental data from mice, and the rarity of inherited mitochondrial disease relative to the age-
dependent accumulation of dysfunctional mtDNA in somatic cells, suggest that a selective sieve operates in 
female germlines to eliminate most, but not all, deleterious mtDNAs [57–59]. Despite purifying selection in 
the germline, there are persistent claims that mitochondrial function of oocytes deteriorates with age and 
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contributes to the age-dependent decline of female fertility [60–62]. Although PGCs and oogonia are 
subject to cellular selection of migratory and proliferative competence, once fetal oocytes have entered 
meiosis, subsequent purifying selection is limited to quality control within cells and selective atresia of 
oocytes that, in older women, have not divided for decades. Mitochondrial aging of oocytes suggests that 
intracellular quality control and atretic losses from an exponentially-declining stock are insufficient to 
maintain mitochondrial function indefinitely in the face of disruptive forces of within-oocyte evolution. 
Mitochondrial	function	deteriorates	with	age	in	somatic	cells	
The imperatives of mitochondrial husbandry differ for female germ cells and somatic cells. The overriding 
goal of germline husbandry is raising high-quality mitochondria for stocking the next generation of bodies. 
By contrast, the overriding goal of somatic husbandry is the lifetime provision of mitochondrial services for 
the ultimate good of the germline. Somatic husbandry should include measures to maintain herd quality 
only to the extent that these measures advance the primary goal of germline support. Mitochondrial 
services may sometimes be provided more economically by ‘cheap fixes’ that deliver benefits now but 
compromise long-term somatic function. 
Classes of mtDNA mutations present in aging somatic cells but absent in younger tissues suggest 
divergent evolutionary processes in germline and soma [63, 64]. Some examples suggest ways in which 
adaptive management of mtDNA evolution might differ between germline and soma. First, germline 
bottlenecks facilitate selective breeding of functional mtDNAs, but similar bottlenecks in somatic tissues 
would come at the metabolic cost of temporarily reduced mitochondrial capacity. Second, oxidative 
phosphorylation in somatic cells can be maintained by functional complementation of mtDNAs that 
individually are unable to sustain function [65, 66], but complementation in the germline would lead to the 
evolutionary replacement of self-sufficient mtDNA lineages by heritable, heteroplasmic consortia that must 
segregate to daughter cells in correct proportions to maintain mitochondrial function. Third, increased 
replication of mtDNA in response to deficient electron transport (reactive biogenesis) is an adaptive 
response to immediate somatic needs that selectively favors less-efficient mtDNAs in the longer-term [24]. 
The short-term fitness benefits of reactive biogenesis may outweigh the long-term costs in somatic cells but 
would be problematic in the female germline. 
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Somatic evolution of mtDNA inevitably proceeds by different paths in different tissues. Mitotic cell 
lineages are subject to cellular selection for faster division. Cellular selection might be a mechanism of 
maintaining functional herds of mitochondria for organismal benefit, but selection for cellular vigor is not 
without organismal risk, given the ever-present danger of cancer [67]. By contrast, evolution of mtDNA in 
postmitotic cell populations will be dominated by selection within cells and extinction of mitochondrial 
herds by unreplaced cell deaths. The 3243A>G mutation of a mitochondrial tRNA is the most common 
inherited cause of mitochondrial myopathy and is found at consistently higher levels in patients’ skeletal 
muscle than in their peripheral blood. Moreover, mutation levels decrease with age in blood, but not 
muscle, suggesting purifying selection against mutant mtDNA in hematopoietic stem cells but not in 
postmitotic muscle [68, 69]. 
Mitochondrial function deteriorates with age, especially in post-mitotic tissues. This decline is 
associated with the accumulation of deleted and otherwise mutated mtDNAs [70]. Mitochondrial aging has 
been reported both in venerable mice and elderly humans despite large differences in body size and 
longevity [71]. Clearly, the rate of deterioration of mitochondrial function has been evolutionarily adjusted 
to species-specific lifespan. This suggests that mtDNA maintenance involves somatic trade-offs and that 
larger longer-lived animals invest more on maintenance of long-term mitochondrial performance [72]. 
Intracellular selection favors mtDNAs that replicate faster than other members of their herd. Variant 
mtDNAs that proliferate within herds despite impairment of cellular function are the mitochondrial 
analogues of cancers [70, 71]. 
Conclusions	and	outlook	
The transfer of most mitochondrial genes to the nucleus circumvented the tragedy of the cytoplasmic 
commons for these genes, but organismal-level selection is relatively inefficient at maintaining cellular 
functions of the remaining mtDNA-encoded genes. This problem appears to have been solved by drastic 
reductions of mtDNA numbers within cells followed by reamplification. Such bottlenecks decrease 
mitochondrial variation within cells, but increase variation among cells, thereby enhancing the efficiency of 
cellular selection on mitochondrial function. Bottlenecks also increase mtDNA uniformity among the many 
cells of offspring, thus enhancing the efficiency of organismal selection. 
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Intracellular selection of mtDNAs is seemingly more efficient than cellular or organismal selection 
because individual mtDNAs are judged directly by their metabolic performance. Why bother with 
bottlenecks if the same end can be achieved by intracellular quality control? Poultry breeding suggests an 
answer. Chicken, like mitochondria, are raised in groups. Artificial selection that chooses parents based on 
individual performance has perpetuated behaviors that increase individual performance at the expense of 
the performance of other group members. Chicken breeders have been able to increase collective yield by 
selection on group performance (analogous to cellular selection) rather than individual performance [75].  
The contributions of mtDNA to cellular fitness within female germlines and to organismal fitness are 
likely to align for housekeeping functions, but soma-specific adaptations of mtDNA are not subject to 
intracellular or cellular selection within female germlines. Over the long-term course of evolution one might 
expect mtDNA to become specialized in housekeeping roles, and somatic adaptations to be delegated to 
nuclear control. Mitochondria have been thoroughly domesticated, and their reproduction tightly 
controlled by nuclear genes, but selfish evolution of mtDNA within germline herds has not been altogether 
eliminated. Mitonuclear conflicts within the female germline are likely to be expressed over the control of 
mtDNA replication, mitophagy, and apoptosis. 
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Figure 1: Mitochondria (colored circles) are contained within cells (inner envelopes) and cells are contained 
within bodies (outer envelopes). Mitochondrial differences exist within cells, among cells within bodies, 
and among bodies. Natural selection and genetic drift can act at all these levels. Mutation generates new 
variants within cells. 
Figure 2: A cell (a) is heteroplasmic for blue and red mitochondria. The cell divides to produce descendant 
cells without a bottleneck (b) or with a bottleneck (b*). Genetic drift occurs at each cell division. The 
effect of the bottleneck is to accentuate drift and increase the differences among cells (compare c and c*). 
The effect of cellular selection is represented at d and d* (the cell with the most blue mitochondria was 
eliminated and replaced by a descendant of the cell with the fewest blue mitochondria). 
